Hypomethylation and hypermethylation of DNA in Wilms tumors

Oncogene

Volumn 21, Issue 43, 2002, Pages 6694-6702

  Ehrlich, Melanie ^a   Jiang, Guanchao ^a   Fiala, Emerich ^b   Dome, Jeffrey S ^c   Yu, Mimi C ^d   Long, Tiffany I ^d,e   Youn, Byungwoo ^b   Sohn, Ock Soon ^b   Widschwendter, Martin ^d,e   Tomlinson, Gail E ^f   Chintagumpala, Murali ^g   Champagne, Martin ^h   Parham, David ⁱ   Liang, Gangning ^e   Malik, Karim ^j   Laird, Peter W ^d,e  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF MONTREAL   (Canada)

ⁱ UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^j UNIVERSITY OF BRISTOL   (United Kingdom)

more..

Author keywords

DNA hypermethylation; DNA hypomethylation; Wilms tumors

Indexed keywords

5 METHYLCYTOSINE; BISULFITE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; RNA METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CHILD; CONTROLLED STUDY; CPG ISLAND; DNA DETERMINATION; DNA HYPERMETHYLATION; DNA HYPOMETHYLATION; DNA METHYLATION; FEMALE; GENE; GENE CALCA; GENE EXPRESSION; GENE MCJ; GENE RASSF1A; GENE TNFRSF12; GENOME; HUMAN; HUMAN TISSUE; INFANT; MALE; NEPHROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENES, TUMOR SUPPRESSOR; HUMANS; KIDNEY NEOPLASMS; NEOPLASM PROTEINS; TUMOR SUPPRESSOR PROTEINS; WILMS TUMOR;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0037179870     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205890     Document Type: Article

References (43)

1. Ahuja N, Li Q, Mohan AL, Baylin SB and Issa JP. (1998). Cancer Res., 58, 5489-5494.
2. Arcellana-Panlilio MY, Egeler RM, Ujack E, Pinto A, Demetrick DJ, Robbins SM and Coppes MJ. (2000). Genes Chromosomes Cancer, 29, 63-69.
3. Baylin SB and Herman JG. (2000). DNA Alterations in Cancer: Genetic and Epigenetic Alterations. Ehrlich M (ed). Natick: Eaton Publishing, pp. 293-309.
4. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky E, White M and Minna JD. (2001). J. Natl. Cancer Inst., 93, 691-699.
5. Busson P, Zhang Q, Guillon JM, Gregory CD, Young LS, Clausse B, Lipinski M, Rickinson AB and Tursz T. (1992). Int. J. Cancer, 50, 863-867.
6. Chapman V, Forrester L, Sanford J, Hastie N and Rossant J. (1984). Nature, 307, 284-286.
7. Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC and Dubeau L. (1997). Br. J. Cancer, 75, 396-402.
8. Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G and Zabarovsky ER. (2001). Proc. Natl. Acad. Sci. USA, 98, 7504-7509.
9. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Danenberg PV and Laird PW. (1999). Cancer Res., 59, 2302-2306.
10. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV and Laird PW. (2000). Nucleic Acids Res., 28, E32.
11. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA and Laird PW. (2001). Cancer Res., 61, 3410-3418.
12. Ehrlich M. (2000). DNA Alterations in Cancer: Genetic and Epigenetic Changes. Ehrlich M (ed). Natick: Eaton Publishing, pp. 273-291.
13. Ehrlich M. (2002). Oncogene, 21, 5400-5413.
14. Ehrlich M, Hopkins N, Jiang G, Dome J, Yu M, Woods C, Tomlinson G, Chintagumpala M, Champagne M, Diller L, Parham D and Sawyer J. (2002). Cancer Genet. Cytogenet, in press.
15. Ehrlich M, Gama-Sosa M, Huang L-H, Midgett RM, Kuo KC, McCune RA and Gehrke C. (1982). Nucleic Acids Res., 10, 2709-2721.
16. Feinberg AP and Vogelstein B. (1983). Nature, 301, 89-92.
17. Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW and Ehrlich M. (1983). Nucleic Acids Res., 11, 6883-6894.
18. Gardiner-Garden M and Frommer M. (1987). J. Mol. Biol., 196, 261-282.
19. Gaughan DJ, Barbaux S, Kluijtmans LA and Whitehead AS. (2000). Gene, 257, 279-289.
20. Grenet J, Valentine V, Kitson J, Li H, Farrow SN and Kidd VJ. (1998). Genomics, 49, 385-393.
21. Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Maslrangel D, Hay RJ, Minna JD and Gazdar AF. (2002). Oncogene, 21, 4345-4349.
22. Hollander M and Wolfe DA. (1973). Nonparametric Statistical Methods. New York: John Wiley and Sons pp 68-75 and 191-194.
23. Issa JP. (2000). DNA Alterations in Cancer: Genetic and Epigenetic Alterations. Ehrlich M (ed). Natick: Eaton Publishing, pp. 311-322.
24. Issa JP, Vertino PM, Boehm CD, Newsham IF and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 11757-11762.
25. Malik K, Salpekar A, Hancock A, Moorwood K, Jackson S, Charles A and Brown KW. (2000). Cancer Res., 60, 2356-2360.
26. Mares J, Kriz V, Weinhausel A, Vodickova S, Kodet R, Haas OA, Sedlacek Z and Goetz P. (2001). Cancer Lett., 166, 165-171.
27. Narayan A, Ji W, Zhang XY, Marrogi A, Graff JR, Baylin SB and Ehrlich M. (1998). Int. J. Cancer, 77, 833-838.
28. Oswald J, Engemann S, Lane N, Mayer W, Olek A, Fundeie R, Dean W, Reik W and Walter J. (2000). Curr. Biol., 10, 475-478.
29. Qu G, Dubeau L, Narayan A, Yu M and Ehrlich M. (1999a). Mut. Res., 423, 91-101.
30. Qu G, Grundy PE, Narayan A and Ehrlich M. (1999b). Cancer Genet. Cytogenet., 109, 34-39.
31. Razin A and Kafri T. (1994). Prog. Nucleic Acid Res. Mol. Biol., 48, 53-81.
32. Ribieras S, Song-Wang X-G, Martin V, Lointier P, Frappart L and Dante R. (1994). J. Cell Biochem., 56, 86-96.
33. Santos F, Hendrich B, Reik W and Dean W. (2002). Dev. Biol., 241, 172-182.
34. Shridhar V, Bible KC, Staub J, Avula R, Lee YK, Kalli K, Huang H, Hartmann LC, Kaufmann SH and Smith DI. (2001). Cancer Res., 61, 4258-4265.
35. Strichman-Almashanu LZ, Lee RS, Onyango PO, Perlman E, Flam F, Frieman MB and Feinberg AP. (2002). Genome Res., 12, 543-554.
36. Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA and Issa JP. (2000). Cancer Res., 60, 4044-4048.
37. Tuck-Muller CM, Narayan A, Tsien F, Smeets D, Sawyer J, Fiala ES, Sohn O and Ehrlich M. (2000). Cytogen. Cell Genet., 89, 121-128.
38. Tycko B. (2000). DNA and Alterations in Cancer: Genetic and Epigenetic Alterations. Ehrlich M (ed). Natick: Eaton Publishing, pp. 333-349.
39. Ushijima T, Morimura K, Hosoya Y, Okonogi H, Tatematsu M, Sugimura T and Nagao M. (1997). Proc. Natl. Acad. Sci. USA, 94, 2284-2289.
40. Wang EC, Kitson J, Thern A, Williamson J, Farrow SN and Owen MJ. (2001). Immunogenetics, 53, 59-63.
41. Wong N, Lam WC, Lai PB, Pang E, Lau WY and Johnson PJ. (2001). Am. J. Pathol., 159, 465-471.
42. Yung R, Ray D, Eisenbraun JK, Deng C, Attwood J, Eisenbraun MD, Johnson K, Miller RA, Hanash S and Richardson B. (2001). J. Gerontol. A Biol. Sci. Med. Sci., 56, B268-B276.
43. Zhang X-Y, Loflin PT, Gehrke CW, Andrews PA and Ehrlich M. (1987). Nucleic Acids Res., 15, 9429-9449.